InvestorsHub Logo
Followers 1
Posts 186
Boards Moderated 0
Alias Born 05/08/2017

Re: None

Thursday, 06/22/2017 1:18:19 PM

Thursday, June 22, 2017 1:18:19 PM

Post# of 12606
Most people expected a price drop due to the CEO telling everyone that the FDA meeting wouldn't be until September. I believe most of the sells were based upon impatient investors. I know some investors personally who sold because they openly admit their impatient. But they said as well that they would return closer to September and reinvest more.

This company has goals and they are accomplishing most of their goals on a skeleton crew and doing good things.

FDA approval doesn't come overnight and neither does amazing gains.

Biostocks are a high reward payout investment but they can take years for that to occur. The biggest payout is having been invested at the stock's lowest price. This is the best time to buy and hold this company stock. If it does get approved which there is no evidence showing it won't, then I can't see the stock price being any less than a few dollars. An approval won't happen this year, more than likely next year in the winter or early 2019.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BICX News